C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2002
10/30/2002	EP1253152A1 Method of converting functional group through halogen-metal exchange reaction
10/30/2002	EP1253148A2 Oxonol dye compound, optical information recording medium using the same, and optical information
10/30/2002	EP1252889A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
10/30/2002	EP1252199A1 Multiple catalyst system
10/30/2002	EP1252162A1 Alpha v integrin receptor antagonists
10/30/2002	EP1252146A1 Amide compounds for inhibiting protein kinases
10/30/2002	EP1252145A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/30/2002	EP1252133A2 Pharmaceutical compounds
10/30/2002	EP1251822A1 Novel coupler for use in oxidative hair dyeing
10/30/2002	EP1004573B1 Aryloxyaniline derivatives
10/30/2002	CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002	CN1377269A Vitronectin receptor antagonists
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1376664A Propynyl or diene diaryl compounds
10/30/2002	CN1093534C Cationic polypeptide condensting agent of pyridine, its synthesis and application
10/29/2002	US6472562 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
10/29/2002	US6472532 Inexpensive method using kojic acid as safe starting material for synthesis of orally active iron chelators
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002	US6472413 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472411 Advanced glycation end-product intermediaries and post-amadori inhibition
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472405 Glycoprotein IIB/IIIA antagonists
10/29/2002	US6472403 αV integrin receptor antagonists
10/29/2002	US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002	US6472399 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/29/2002	US6472349 Pyridine-2,3-dicarboxylic acid diamides
10/29/2002	US6472348 Pyridone derivatives and herbicides
10/29/2002	US6472341 Polymerization catalysts
10/29/2002	US6472100 Cathode contains oxyhydroxide of nickel and aluminum, may further contain oxyhydroxide of cobalt; improvement in cycle life; electrolyte containing heterocyclic compound containing nitrogen having lone pair; pyridine, pyrazine, pyridazine,
10/29/2002	CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/24/2002	WO2002083842A2 Small molecule inhibitors of secretion of proteins encoded by are-mrnas
10/24/2002	WO2002083662A2 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002002714A3 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/24/2002	WO2002002516A3 Inhibitors of hiv integrase
10/24/2002	US20020156313 Process for preparation of 2-phenyl acetic acid derivatives
10/24/2002	US20020156295 Coordination catalyst containing ligand
10/24/2002	US20020156281 Anticholesterol agents; cardiovascular disorders; antilipemic agents; restenosis; dietetics
10/24/2002	US20020156279 Substituted pyridyl amine catalysts and processes for polymerizing crystalline polymers
10/24/2002	US20020156122 Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/24/2002	US20020156113 Farnesyl transferase inhibitors; anticancer agents
10/24/2002	US20020156089 Use of CRF antagonists and related compositions
10/24/2002	US20020156087 Pyrimidine or pyridine derivatives
10/24/2002	US20020156075 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
10/24/2002	US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis
10/24/2002	US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/24/2002	US20020156018 Treating parasitic diseases, which are mediated by such proteases. In particular, treating malaria by inhibiting the cysteine protease falcipain.
10/24/2002	US20020155470 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/24/2002	US20020155399 Using pyridinium compound as templete
10/24/2002	CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002	CA2443699A1 Phenyl heterocyclyl ether
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them
10/23/2002	EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002	EP1250315A1 Functional monomers for molecular recognition and catalysis
10/23/2002	EP1250303A1 Method for preparing alpha-halogenated ketones
10/23/2002	EP1250047A2 Herbicidal composition
10/23/2002	EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002	EP1098880A4 Dechlorination of pyridines in acidic, zinc-containing mediums
10/23/2002	CN1376153A Amide compounds
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376145A A meta-nitro phenol derivative and a process for producing it
10/23/2002	CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002	CN1093125C Sulfamide-metalloprotease inhibitors
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002	CN1093121C Process for preparation of 2,3,5-collidine and 2-ethyl-5-methyl pyridine
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002	US6469224 Reacting a phosphazenium compound with a halogenated aromatic compounds, especially chlorinated aromatic compounds
10/22/2002	US6469193 Efficient synthesis of alkyl carbonates
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469038 Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
10/22/2002	US6469034 Cyclohexenyl-ethyl-thiourea compounds for inhibiting HIV reverse transcriptase
10/22/2002	US6469033 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
10/22/2002	US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002	US6469005 Propargylether derivatives
10/22/2002	US6468741 Electrochemiluminescent rhenium moieties
10/17/2002	WO2002081484A1 Tumour inhibiting gallium compounds
10/17/2002	WO2002081483A2 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002080912A1 Reconstitutable parenteral composition containing a cox-2 inhibitor
10/17/2002	WO2002080869A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye
10/17/2002	WO2002067053A3 High speed photothermographic materials containing tellurium compounds and methods of using same
10/17/2002	WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002	WO2002050007A3 Substituted stilbenes, their reactions and anticancer activity
10/17/2002	WO2002049967A3 Novel multidentate sulfur-containing ligands
10/17/2002	WO2002026712A3 Quaternary amines and related inhibitors of factor xa
10/17/2002	WO2001096283A9 Hiv integrase inhibitors
10/17/2002	WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002	US20020151719 Vapor phase fluid catalysis with alkali metal enables recycling and reuse of unreacted ammonia; fluidization to remove heat of reaction
10/17/2002	US20020151572 Nitric oxide synthase (NOS); alone or in combination with another active agent for the treatment of psoriasis, an antiinflammatory, an analgesic, a cognition enhancer or sleep disorder treatment

1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 633